Portfolio company
UroMems
France · £19.6m raised
Raised
£19.6m
Latest stage
Series B
Rounds recorded
1
Backed by
1 investor
Sectors
About
UroMems develops an automated implantable electronic artificial urinary sphincter to treat stress urinary incontinence in male and female patients.
SourceFunding history · 1
Similar companies
Audaxis Medical
The company develops polyurethane implants to treat stress urinary incontinence in women.
MYOPOWERS MEDICAL TECHNOLOGIES SA
This company develops implantable artificial muscle technology to restore muscle function for patients suffering from conditions such as stress urinary incontinence.
Stimuli
This company develops a medical device using transcutaneous electrical nerve stimulation to treat adults suffering from overactive bladder symptoms and urinary urgency.
Avation Medical
This company develops non-invasive wearable neuromodulation systems to treat patients suffering from overactive bladder and urinary incontinence.
Pelvital
Pelvital produces an at-home medical device that delivers mechanotherapy to treat stress urinary incontinence and strengthen pelvic floor muscles for women.
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
LiGalli
The company develops an intelligent intravaginal ring for controlled drug delivery and diagnostic monitoring for women with conditions such as overactive bladder.
Amber Therapeutics
This company develops an implantable adaptive neuromodulation system to treat women suffering from mixed urinary incontinence.
